Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2182 (112th)

Generating Antibiotic Incentives Now Act of 2011

referredUnited States· United States Congress· EN

Introduced

15 June 2011

Last action

16 June 2011 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Gingrey, Phil [R-GA-11], Rep. Green, Gene [D-TX-29], Rep. Whitfield, Ed [R-KY-1], Rep. DeGette, Diana [D-CO-1], Rep. Rogers, Mike J. [R-MI-8], Rep. Eshoo, Anna G. [D-CA-18], Rep. Shimkus, John [R-IL-15], Rep. Bilbray, Brian P. [R-CA-50], Rep. Harper, Gregg [R-MS-3], Sen. Blackburn, Marsha [R-TN], Rep. Lance, Leonard [R-NJ-7], Rep. Myrick, Sue Wilkins [R-NC-9], Rep. Sullivan, John [R-OK-1], Rep. Burgess, Michael C. [R-TX-26], Rep. Latta, Robert E. [R-OH-5], Rep. Griffith, H. Morgan [R-VA-9], ROBERT BRADY, Sen. Murphy, Christopher [D-CT], Sen. Markey, Edward J. [D-MA], Rep. Keating, William R. [D-MA-9], Rep. Inslee, Jay [D-WA-1], Rep. Meehan, Patrick [R-PA-7], Rep. Carney, John C., Jr. [D-DE-At Large], Rep. Miller, Brad [D-NC-13], Rep. Burton, Dan [R-IN-5], Rep. Butterfield, G. K. [D-NC-1], Rep. Guthrie, Brett [R-KY-2], Rep. McCaul, Michael T. [R-TX-10], Sen. Cassidy, Bill [R-LA], Rep. Brooks, Mo [R-AL-5], Rep. Broun, Paul C. [R-GA-10], Rep. McMorris Rodgers, Cathy [R-WA-5], Rep. Himes, James A. [D-CT-4], Rep. McHenry, Patrick T. [R-NC-10], Rep. Walden, Greg [R-OR-2], Rep. Tsongas, Niki [D-MA-3], Rep. Matheson, Jim [D-UT-2], Rep. Gonzalez, Charles A. [D-TX-20], Rep. Matsui, Doris O. [D-CA-7], Rep. Latham, Tom [R-IA-3], Rep. Filner, Bob [D-CA-51], Rep. Miller, Gary G. [R-CA-42], Rep. Barrow, John [D-GA-12], Rep. Kinzinger, Adam [R-IL-16], Rep. Benishek, Dan [R-MI-1], Rep. Ross, Mike [D-AR-4], Del. Christensen, Donna M. [D-VI-At Large]

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Summary

Generating Antibiotic Incentives Now Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to extend the exclusivity period for a new prescription drug by five years for a drug that the Secretary of Health and Human Services (HHS) determines to be a qualified infectious disease product. Defines "qualified infectious disease product" to mean an antibiotic drug for treating, detecting, preventing, or identifying a qualifying pathogen (certain pathogens that are resistant to antibiotics). Excludes drugs that are: (1) a supplement to a new drug application for which an extension is in effect or has expired; or (2) a subsequent application for a change that results in a new indication, route of administration, dosing schedule, dosage form, delivery system, delivery device or strength, or a modification to the structure of the product that does not result in a change in safety or effectiveness. Extends such period of exclusivity an additional six months for a sponsor or manufacturer of a qualified infectious disease product that identifies a companion diagnostic test. Requires the Secretary to give priority review to any drug determined to be a qualified infectious disease product. Includes qualified infectious disease products as fast track products for which the Secretary shall facilitate development and expedite review. Directs the Comptroller General to study the need for incentives to encourage the research, development, and marketing of qualified infectious disease biological products. Requires the Secretary to: (1) review Food and Drug Administration (FDA) guidelines for clinical trials of antibiotic drugs; and (2) revise such guidelines, as appropriate, to reflect developments in scientific and medical information and technology and to ensure clarity regarding the procedures and requirements for approval of an antibiotic drug.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 15 June 2011

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 15 June 2011

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 15 June 2011

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 16 June 2011

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 15 June 2011

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 15 June 2011

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 15 June 2011

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.